Indeed, our laboratory has previously shown through microarray analysis that immune response and interferon signaling pathways are significantly altered in AI-resistant breast cancer cells and that several interferon response genes including IFITM1, PLSCR1 and STAT1 are constitutively overexpressed in AI-resistant breast cancer cells [17,24]. This evidence concerns the gene PLSCR1 and breast carcinoma.